Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 194

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Screening, diagnosis, and management of patients with Fabry disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

Open access
Schiffmann, Raphael, Hughes, Derralynn A., Linthorst, Gabor E., Ortiz, Alberto, Svarstad, Einar, Warnock, David G., West, Michael L., Wanner, Christoph, Bichet, Daniel G., Christensen, Erik Ilsø, Correa-Rotter, Ricardo, Elliott, Perry M., Feriozzi, Sandro, Fogo, Agnes B., Germain, Dominique P., Hollak, Carla E.M., Hopkin, Robert J., Johnson, Jack, Kantola, Ilkka, Kopp, Jeffrey B., Kröner, Jürgen, Linhart, Aleš, Martins, Ana Maria, Matern, Dietrich, Mehta, Atul B., Mignani, Renzo, Najafian, Behzad, Narita, Ichiei, Nicholls, Kathy, Obrador, Greg T., Oliveira, João Paulo, Pisani, Antonio, Politei, Juan, Ramaswami, Uma, Ries, Markus, Terryn, Wim, Tøndel, Camilla, Torra, Roser, Vujkovac, Bojan, Waldek, Stephen, Walter, Jerry · 2017 · Kidney International

Abstract

Patients with Fabry disease (FD) are at a high risk for developing chronic kidney disease and cardiovascular disease. The availability of specific but costly therapy has elevated the profile of this rare condition. This KDIGO conference addressed controversial areas in the diagnosis, screening, and management of FD, and included enzyme replacement therapy and nonspecific standard-of-care therapy for the various manifestations of FD. Despite marked advances in patient care and improved overall outlook, there is a need to better understand the pathogenesis of this glycosphingolipidosis and to determine the appropriate age to initiate therapy in all types of patients. The need to develop more effective specific therapies was also emphasized.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.kint.2016.10.004

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 194

Metadata

Authors
Schiffmann, R., Hughes, D. A., Linthorst, G. E., Ortiz, A., Svarstad, E., Warnock, D. G., West, M. L., Wanner, C., Bichet, D. G., Christensen, E. I., Correa-Rotter, R., Elliott, P. M., Feriozzi, S., Fogo, A. B., Germain, D. P., Hollak, C. E. M., Hopkin, R. J., Johnson, J., Kantola, I., Kopp, J. B., Kröner, J., Linhart, A., Martins, A. M., Matern, D., Mehta, A. B., Mignani, R., Najafian, B., Narita, I., Nicholls, K., Obrador, G. T., Oliveira, J. P., Pisani, A., Politei, J., Ramaswami, U., Ries, M., Terryn, W., Tøndel, C., Torra, R., Vujkovac, B., Waldek, S., & Walter, J.
Venue
Kidney International
Publisher
Elsevier BV
Published
2017-02
Volume
91
Issue
2
Pages
284-293
ISSN
0085-2538 (ISSN-L)
OpenAlex
W2562426643
Cited by
194
References
8
FWCI
10.27
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.